LACTOSE INTOLERANCE — GENETIC

Lactose Intolerance — a trait present in 65% of the global population that in its common form is genetic adaptation, but in its rare congenital form (CLD) is a neonatal emergency requiring immediate formula change.

Whole genome sequencing distinguishes genetic lactase non-persistence (common, benign) from congenital lactase deficiency (rare, neonatal emergency) and sucrase-isomaltase deficiency — providing the clinical precision that symptom presentation alone cannot supply.

LCT
MCM6

About this condition

Lactose Intolerance — Genetic

Lactose intolerance in its most common form — adult-onset primary lactase deficiency — is caused by the developmental decline in lactase-phlorizin hydrolase (LPH) expression in the small intestinal brush border that occurs in most mammals after weaning. In most humans, LCT gene expression declines after early childhood — a state called lactase non-persistence (LNP). The minority ancestral adaptation, lactase persistence (LP), evolved independently multiple times in populations with a history of dairying cattle — Northern Europeans (LP allele frequency ~90%), some East African pastoralist groups (~50-80%), and certain Middle Eastern and South Asian populations. The genetic basis of LP involves regulatory single-nucleotide variants upstream of the LCT gene in the MCM6 intron, of which c.-13910C>T (rs4988235) is the primary European LP variant.

Primary lactase non-persistence affects approximately 65% of the global adult population and causes symptoms of lactose malabsorption — bloating, abdominal cramps, flatulence, and diarrhea — after lactose consumption exceeding a variable threshold. The condition is not a disease, but rather the ancestral mammalian norm, and its severity and symptom threshold vary widely. Distinguishing primary LNP from the rare but clinically distinct condition of congenital lactase deficiency (CLD), caused by pathogenic variants in the LCT structural gene itself, is clinically important: CLD presents in the neonatal period with profuse watery diarrhea immediately after the first lactose-containing feed, causing severe dehydration. CLD is most common in Finland (LGLS variants) and requires immediate switch to lactose-free formula.

Sucrase-isomaltase deficiency — caused by pathogenic variants in MGAM (maltase-glucoamylase) or SI (sucrase-isomaltase) — produces symptoms indistinguishable from lactose intolerance but requires dietary sucrose restriction rather than lactose restriction, and is treatable with sacrosidase (Sucraid). Trehalase deficiency (TREH variants) similarly causes carbohydrate intolerance superficially resembling lactose intolerance. These mechanistically different conditions are important to distinguish in patients with refractory 'lactose intolerance' symptoms who remain symptomatic despite dairy exclusion. Whole genome sequencing evaluates LCT, MCM6, SI, MGAM, and TREH simultaneously.

Congenital lactase deficiency (CLD), caused by LCT coding variants, is a rare neonatal emergency — presenting within days of first feeding with profuse watery diarrhea, dehydration, and failure to thrive. It is distinct from common adult lactase non-persistence and requires immediate dietary management.

Gene locus: LCT/MCM6 (2q21.3)

Breath tests diagnose lactose malabsorption. They do not distinguish common genetic LNP from congenital LCT deficiency or sucrase-isomaltase deficiency — conditions with different dietary treatments. Molecular genotyping provides this distinction.

Patients with persistent symptoms after dairy exclusion may have sucrase-isomaltase deficiency — not lactose intolerance

Sucrase-isomaltase (SI) deficiency is estimated to affect 0.2% of Northern Europeans and up to 5% of Greenlandic Inuit, causing disaccharide intolerance with symptoms almost identical to lactose intolerance. Patients with SI deficiency who eliminate dairy often remain symptomatic because sucrose in bread, fruit, and sweetened foods is the actual trigger. SI deficiency is treatable with sacrosidase enzyme supplementation (Sucraid, FDA-approved). A genome-wide analysis evaluating LCT, MCM6, SI, MGAM, and TREH simultaneously can identify the specific genetic cause of carbohydrate intolerance — distinguishing conditions with different dietary exclusions and different treatment approaches from what is presented as 'refractory lactose intolerance.'

The MCM6 regulatory variant determines lifetime dairy tolerance — a permanent trait worth knowing definitively

The MCM6 c.-13910C>T variant — the primary European lactase persistence allele — is a simple Mendelian trait. Homozygous CC (non-persistence) individuals have low adult lactase expression and are typically lactose intolerant as adults. Homozygous TT or heterozygous CT (persistence) individuals maintain lactase expression. Knowing this genotype definitively — rather than inferring it from a hydrogen breath test that can be confounded by rapid transit, small intestinal bacterial overgrowth, and other variables — provides a permanent, unambiguous result that determines the dietary approach without repeat testing. For individuals of non-European ancestry, additional LP regulatory variants (1390G, 14011G) relevant to East African and Middle Eastern populations are also evaluated by whole genome sequencing.

Lactose Intolerance — a trait present in 65% of the global population that in its common form is genetic adaptation, but in its rare congenital form (CLD) is a neonatal emergency requiring immediate formula change.

Lactose Intolerance — Genetic

Breath tests diagnose lactose malabsorption. They do not distinguish common genetic LNP from congenital LCT deficiency or sucrase-isomaltase deficiency — conditions with different dietary treatments. Molecular genotyping provides this distinction.

Patients with persistent symptoms after dairy exclusion may have sucrase-isomaltase deficiency — not lactose intolerance

The MCM6 regulatory variant determines lifetime dairy tolerance — a permanent trait worth knowing definitively

Others in Metabolic

One test. A lifetime of answers.